Omalizumab in the treatment of allergic bronchopulmonary aspergillosis: One center's experience with 14 cases

Allergy and Asthma Proceedings

Volumn 36, Issue 6, 2015, Pages 493-500

  Aydn, Omur ^a   Sozener, Zeynep Celebi ^a   Soyyigit, Sadan ^a   Kendirlinan, Resat ^a   Gencturk, Zeynep ^a   Msrlgil, Zeynep ^a   Mungan, Dilsad ^a   Sin, Betul Ayse ^a   Demirel, Yavuz Selim ^a   Celik, Gulfem Elif ^a   Bavbek, Sevim ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; IMMUNOGLOBULIN E; ITRACONAZOLE; LONG ACTING DRUG; MONTELUKAST; OMALIZUMAB; ANTIALLERGIC AGENT; FUNGUS ANTIBODY;

ADULT; ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ANTIMICROBIAL THERAPY; ARTICLE; ASTHMA; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE CONTROL; DISEASE EXACERBATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; DRUG WITHDRAWAL; EOSINOPHIL COUNT; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HOSPITALIZATION; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INJECTION; LIVER FUNCTION TEST; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; OUTCOME ASSESSMENT; RECOMMENDED DRUG DOSE; RETROSPECTIVE STUDY; SIDE EFFECT; TREATMENT DURATION; YOUNG ADULT; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; DISEASE COURSE; IMMUNOLOGY; LUNG FUNCTION TEST; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ADULT; ANTI-ALLERGIC AGENTS; ANTIBODIES, FUNGAL; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; OMALIZUMAB; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84948679891     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2015.36.3909     Document Type: Article

References (20)

1. Bains SN, and Judson MA. Allergic bronchopulmonary aspergillosis. Clin Chest Med 33:265-281, 2012
2. Homma T, Kurokawa M, Matsukura S, et al. Anti-IgE therapy for allergic bronchopulmonary aspergillosis. J Microbiol Immunol Infect S1684-1182:00197-00197, 2013
3. Knutsen AP, and Slavin RG. Allergic bronchopulmonary aspergillosis in asthma and cystic fibrosis. Clin Dev Immunol 2011: 843763, 2011
4. Tillie-Leblond I, and Tonnel AB. Allergic bronchopulmonary aspergillosis. Allergy 60:1004-1013, 2005
5. Agarwal R, Chakrabarti A, Shah A, et al. ABPA complicating asthma ISHAM working group. Allergic bronchopulmonary aspergillosis: Review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy 43:850-873, 2013
6. Moss RB. Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis. Eur Respir J 43:1487-1500, 2014
7. Collins J, Devos G, Hudes G, and Rosenstreich D. Allergic bronchopulmonary aspergillosis treated successfully for one year with omalizumab. J Asthma Allergy 5:65-70, 2012
8. Tillie-Leblond I, Germaud P, Leroyer C, et al. Allergic bronchopulmonary aspergillosis and omalizumab. Allergy 66:1254-1256, 2011
9. Sastre I, Blanco J, Mata H, and Garca F. A case of allergic bronchopulmonary aspergillosis treated with omalizumab. J Investig Allergol Clin Immunol 22:145-147, 2012
10. van der Ent CK, Hoekstra H, and Rijkers GT. Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibody. Thorax 62:276-277, 2007. inelevel0
11. Lehmann S, Pfannenstiel C, Friedrichs F, et al. Omalizumab: A new treatment option for allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Ther Adv Respir Dis 8:141-149, 2014
12. Bavbek S, Aydn O, Kepil Ozdemir S, et al. Therapy with omalizumab in patients with severe persistent allergic asthma: A real life data in Turkey. Tuberk Toraks 58:425-434, 2010
13. Greenberger PA. Chapter 18: Allergic bronchopulmonary aspergillosis. Allergy Asthma Proc 33(suppl. 1):S61-S63, 2012
14. Mikita CP, and Mikita JA. Allergic bronchopulmonary aspergillosis. Allergy Asthma Proc 27:82-84, 2006
15. Greenberger PA, Bush RK, Demain JG, et al. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol Pract 2:703-708, 2014
16. Perez-de-Llano LA, Vennera MC, Parra A, et al. Effects of omalizumab in Aspergillus-Associated airway disease. Thorax 66:539-540, 2011
17. Schatz M, Kosinski M, Yarlas AS, et al. The minimally important difference of the Asthma Control Test. J Allergy Clin Immunol 124:719-723, 2009
18. Domingo C, Moreno A, Jose Amengual M, et al. Omalizumab in the management of oral corticosteroid-dependent IGE-mediated asthma patients. Curr Med Res Opin 27:45-53, 2011
19. Lai T, Wang S, Xu Z, et al. Long-term efficacy and safety of omalizumab in patients with persistent uncontrolled allergic asthma: A systematic review and meta-Analysis. Sci Rep 3;5: 8191, 2015
20. Quintas Vazquez LM, Piquer MO, and Perez de Llano LA. Effective anti-immunoglobulin-E antibody treatment of a patient with allergic bronchopulmonary aspergillosis [in Spanish]. Arch Bronconeumol 5:207, 2009